ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SPHR Sphere Medical

0.40
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Sphere Medical LSE:SPHR London Ordinary Share GB00B551W951 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.40 0.35 0.45 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Sphere Medical Holding plc Sphere Medical Expands Sales into Belgium (3614I)

30/08/2016 7:01am

UK Regulatory


Sphere Medical (LSE:SPHR)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Sphere Medical Charts.

TIDMSPHR

RNS Number : 3614I

Sphere Medical Holding plc

30 August 2016

 
 
 

30 August 2016

Sphere Medical Holding plc

("Sphere Medical" or the "Company")

Sphere Medical Expands Sales into Belgium

Sphere Medical Holding plc (AIM: SPHR.L), a leading provider of innovative monitoring and diagnostic devices for the critical care setting, announces the first sale of its Proxima system in Belgium with an initial order to the Universitair Ziekenhuis Brussel, a 700 bed teaching hospital conducting scientific research, which has evaluated the Proxima system during the past year.

After the UK and Germany, Belgium is the third country in which Sphere Medical has sold Proxima devices through its direct sales force.

Dr Wolfgang Rencken, Chief Executive Officer of Sphere Medical, said: "Proxima is an innovative product which offers better patient management during a patient's critical period, and faster and more frequent production of blood gas, electrolyte and metabolite results. We are pleased to bring Proxima to patients around Europe and report sales in three countries now. As we look ahead to the launch of Proxima 4, the opportunity to increase potential coverage from around 10% of critical care patients to 40-50% gives us optimism for the future."

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

- Ends -

For further information, please contact:

 
Sphere Medical Holding                     Tel: +44 (0)1223 875 
 plc                                                        222 
Dr Wolfgang Rencken, Chief 
 Executive Officer 
Richard Wright, Chief 
 Financial Officer 
 
Panmure Gordon                             Tel: +44 (0) 20 7886 
                                                           2500 
Freddy Crossley (Corporate 
 Finance) 
Duncan Monteith (Corporate 
 Finance) 
Tom Salvesen (Corporate 
 Broking) 
 
Consilium Strategic                        Tel: +44 (0) 20 3709 
 Communications                                            5700 
Mary-Jane Elliott             spheremedical@consilium-comms.com 
Chris Gardner 
 Ivar Milligan 
Hendrik Thys 
 
 

Notes for Editors

About Sphere Medical (AIM: SPHR.L)

Sphere Medical is an innovative point-of-care medical device company. Its Proxima platform measures blood gases, electrolytes and metabolites at the patient's bedside and aims to improve patient care and reduce health system costs. The device is currently sold directly to the critical care market via Sphere Medical's sales force in the UK, Germany, The Netherlands and Belgium. For further information, please visit www.spheremedical.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCPLMBTMBATTIF

(END) Dow Jones Newswires

August 30, 2016 02:01 ET (06:01 GMT)

1 Year Sphere Medical Chart

1 Year Sphere Medical Chart

1 Month Sphere Medical Chart

1 Month Sphere Medical Chart

Your Recent History

Delayed Upgrade Clock